{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:05:03Z","timestamp":1793394303747,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.revmed.2010.09.007","type":"journal-article","created":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T04:16:43Z","timestamp":1288498603000},"page":"605-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Les syndromes neurologiques paran\u00e9oplasiques"],"prefix":"10.1016","volume":"32","author":[{"given":"A.","family":"Didelot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2010.09.007_bib0005","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1056\/NEJM199906103402311","article-title":"The importance of defining the paraneoplastic neurologic disorders","volume":"340","author":"Darnell","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2010.09.007_bib0010","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2010.09.007_bib0015","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/brain\/awh247","article-title":"FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes","volume":"127","author":"Younes-Mhenni","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2010.09.007_bib0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11307-008-0134-7","article-title":"Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates","volume":"10","author":"Basu","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0025","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1212\/WNL.0b013e3181d25b80","article-title":"Neurosarcoidosis with diencephalitis and anti-Ma2\u00a0antibodies","volume":"74","author":"Desestret","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2006.00621.x","article-title":"Autopsy findings in the nervous system and ovarian tumour of two patients with paraneoplastic cerebellar degeneration","volume":"183","author":"Storstein","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.revmed.2010.09.007_bib0035","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","article-title":"Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55\u00a0anti-Yo antibody-positive patients","volume":"42","author":"Peterson","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/WNL.55.5.713","article-title":"Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies","volume":"55","author":"Rojas","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","article-title":"Onconeural antibodies and tumor type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5\u00a0antibodies","volume":"80","author":"Honnorat","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2010.09.007_bib0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","article-title":"Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease","volume":"60","author":"Bernal","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0055","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-003-0203-4","article-title":"Myorhythmia associated with Hodgkin's lymphoma","volume":"250","author":"Wiener","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0060","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/01.WNL.0000113749.77217.01","article-title":"Antibodies to Zic4\u00a0in paraneoplastic neurologic disorders and small-cell lung cancer","volume":"62","author":"Bataller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.1288","article-title":"Molecular and clinical diversity in paraneoplastic immunity to Ma proteins","volume":"50","author":"Rosenfeld","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0070","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50\u00a0patients","volume":"126","author":"Shams\u2019ili","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2010.09.007_bib0075","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/120.8.1279","article-title":"Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome","volume":"120","author":"Mason","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2010.09.007_bib0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jnnp.11.2.73","article-title":"Primary sensory neuropathy with muscular changes associated with carcinoma","volume":"11","author":"Denny-Brown","year":"1948","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2010.09.007_bib0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.40.2.219","article-title":"Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis","volume":"40","author":"Graus","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0090","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI1130","article-title":"Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle","volume":"101","author":"Gill","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2010.09.007_bib0095","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awp136","article-title":"The pattern and diagnostic criteria of sensory neuronopathy: a case-control study","volume":"132","author":"Camdessanche","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2010.09.007_bib0100","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ana.410440620","article-title":"Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy","volume":"44","author":"Molinuevo","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0105","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neurol.2008.08.001","article-title":"Paraneoplastic peripheral neuropathies","volume":"164","author":"Antoine","year":"2008","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.revmed.2010.09.007_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu \u2013 associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71\u00a0patients","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2010.09.007_bib0115","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","article-title":"Management of paraneoplastic neurological syndromes: report of an EFNS Task Force","volume":"13","author":"Vedeler","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert-Eaton myasthenic syndrome. A review of 50\u00a0cases","volume":"111","author":"O\u2019Neill","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2010.09.007_bib0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0035-3787(04)70888-7","article-title":"Lambert-Eaton myasthenic syndrome","volume":"160","author":"Newsom-Davis","year":"2004","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.revmed.2010.09.007_bib0130","first-page":"24","article-title":"Limbic encephalitis: a probably under-recognized syndrome","volume":"20","author":"Graus","year":"2005","journal-title":"Neurologia"},{"key":"10.1016\/j.revmed.2010.09.007_bib0135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1\u00a0antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"70","author":"Sabater","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.10392","article-title":"Reduction of P\/Q-type calcium channels in the post-mortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome","volume":"53","author":"Fukuda","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/mus.21315","article-title":"Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction","volume":"40","author":"Pellkofer","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2010.09.007_bib0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/91.3.481","article-title":"\u201cLimbic encephalitis\u201d and its association with carcinoma","volume":"91","author":"Corsellis","year":"1968","journal-title":"Brain"},{"issue":"Pt 8","key":"10.1016\/j.revmed.2010.09.007_bib0155","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain J Neurol"},{"issue":"Pt 3","key":"10.1016\/j.revmed.2010.09.007_bib0160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2010.09.007_bib0165","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"The epilepsy related protein Lgi1, is the antigen of Limbic Encephalitis previously attributed to potassium channels","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0170","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1\u00a0potassium channel-complex proteins leucine-rich, glioma inactivated\u00a01\u00a0protein and contactin-associated protein-2\u00a0in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2010.09.007_bib0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0180","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0190","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0883073809343319","article-title":"Expanding spectrum of encephalitis with NMDA receptor antibodies in young children","volume":"25","author":"Lebas","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0195","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/WNL.0b013e3181cb3e52","article-title":"Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor","volume":"74","author":"Bataller","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181d3e404","article-title":"The expanding clinical profile of anti-AMPA receptor encephalitis","volume":"74","author":"Graus","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0215","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","article-title":"Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates","volume":"128","author":"Ances","year":"2005","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jnnp.2008.158246","article-title":"Anti-Hu-associated brainstem encephalitis","volume":"80","author":"Saiz","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2010.09.007_bib0225","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200\u00a0patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2010.09.007_bib0230","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/gut.2004.043968","article-title":"Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction","volume":"53","author":"De Giorgio","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.revmed.2010.09.007_bib0235","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.53.6.1233","article-title":"Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability","volume":"53","author":"Vernino","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0240","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00247-009-1282-x","article-title":"The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review","volume":"39","author":"Rothenberg","year":"2009","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0245","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410290303","article-title":"Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer","volume":"29","author":"Luque","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jso.20103","article-title":"Anti-Ri antibody opsoclonus-myoclonus syndrome and breast cancer: a case report and a review of the literature","volume":"87","author":"Weizman","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0255","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00431-006-0247-4","article-title":"Long-term outcome of 10\u00a0children with opsoclonus-myoclonus syndrome","volume":"166","author":"Klein","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"Suppl. 1","key":"10.1016\/j.revmed.2010.09.007_bib0260","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.revmed.2004.04.008","article-title":"Treatment of polymyositis and dermatomyositis","volume":"25","author":"Cherin","year":"2004","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2010.09.007_bib0265","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/01.wnl.0000252379.81933.80","article-title":"Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis","volume":"68","author":"Mathew","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.09.007_bib0270","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.revmed.2009.06.001","article-title":"Burn-out chez un militaire","volume":"30","author":"Masson","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2010.09.007_bib0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I","article-title":"Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration","volume":"47","author":"Albert","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0280","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.coi.2004.07.009","article-title":"Neuro-immunology of the paraneoplastic neurological degenerations","volume":"16","author":"Roberts","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0285","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2008.03.002","article-title":"Regulatory\u00a0T cells in paraneoplastic neurological syndromes","volume":"196","author":"Tani","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2010.09.007_bib0290","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2010.09.007_bib0295","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2008.02246.x","article-title":"EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases","volume":"15","author":"Elovaara","year":"2008","journal-title":"Eur J Neurol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310009859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310009859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:28:39Z","timestamp":1759336119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866310009859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0248866310009859"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2010.09.007","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les syndromes neurologiques paran\u00e9oplasiques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2010.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}